
In the realm of medical treatment, combining various therapies has brought about a significant shift in patient care. This approach has also made its mark in the management of inflammatory bowel disease (IBD), offering a plethora of new medication choices. However, a notable limitation has surfaced, termed the 'therapeutic ceiling,' as no single treatment appears to be highly effective for more than 20-30% of IBD patients. While the availability of treatment options has expanded, concerns loom over the potential adverse effects of integrating advanced therapies in IBD treatment. Balancing the benefits of combining treatments with the risks remains a pivotal concern in the quest for more effective IBD management.
Like
Save
Share